CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shanghai Fudan Forward S&T Co Ltd Company Snapshot
Shanghai Fudan Forward S&T Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Fudan Forward S&T Co Ltd with three other companies in this sector in China: Beijing Science Sun Pharmaceutical Co Ltd (2017 sales of 749.99 million Chinese Renmimbi [US$107.89 million] of which 100% was Phamaceutical Manufacturing Industry), Wuhan Hiteck Biological Pharma Co Ltd (750.26 million Chinese Renmimbi [US$107.93 million] of which 99% was Medicine Manufacture), and Shandong Wohua Pharmaceutical Co., Ltd. (726.65 million Chinese Renmimbi [US$104.54 million] of which 100% was Medical Industry).

Sales Analysis. During the year ended December of 2017, sales at Shanghai Fudan Forward S&T Co Ltd were 735.73 million Chinese Renmimbi (US$105.84 million). This is an increase of 9.7% versus 2016, when the company's sales were 670.57 million Chinese Renmimbi. Sales of Industrial saw an increase that was more than double the company's growth rate: sales were up 24.6% in 2017, from 375.09 million Chinese Renmimbi to 467.30 million Chinese Renmimbi. Not all segments of Shanghai Fudan Forward S&T Co Ltd experienced an increase in sales in 2017: sales of Other Operations fell 65.7% to 12.49 million Chinese Renmimbi. Shanghai Fudan Forward S&T Co Ltd also experienced decreases in sales in Software Development (down 11.0% to 231.21 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shanghai Fudan Forward S&T Co Ltd
  Stock Performance Chart for Shanghai Fudan Forward S&T Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (11/16/2018): 8.14
(Figures in Chinese Renmimbi)
1 Week 21.7%   13 Weeks 102.0%  
4 Weeks 63.8%   52 Weeks 19.0%  
 
Shanghai Fudan Forward S&T Co Ltd Key Data:
  Ticker: 600624 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 735,729,241
(Year Ending Jan 2018).
Employees: 1,522
  Currency: Chinese Renmimbi Market Cap: 5,573,555,761
  Fiscal Yr Ends: December Shares Outstanding: 684,712,010
  Share Type: A Gu Closely Held Shares: 254,399,804
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.